Endocrinology News

LONG BEACH, Calif. — A prognostic kidney test and medication management in patients with diabetic kidney disease was tied to use of cardiorenal protective medications and improved hypertension control, according to data presented here.

Individuals prescribed the antidiabetes treatment metformin less likely developed a myeloproliferative neoplasm —potentially also reducing a person’s chances for developing certain cancers — according to data published in Blood Advances.

SAN FRANCISCO — In two phase 3 trials, the nonhormonal investigational agent elinzanetant was associated with decreased frequency and severity of menopausal vasomotor symptoms over 12 weeks with a favorable safety profile.

Glucocorticoid tapering, education and treatment of adrenal crisis are three of the main focuses of a new clinical practice guideline on glucocorticoid-induced adrenal insufficiency.

In patients with type 2 diabetes who underwent ablation for atrial fibrillation, those taking a GLP-1 receptor agonist had lower risk for AF recurrence, mortality and other outcomes, researchers reported at Heart Rhythm 2024.

A once-weekly basal insulin conferred noninferior reductions in HbA1c among insulin-naive adults with type 2 diabetes and those who receive multiple daily insulin injections, according to top-line results from two phase 3 trials.

NEW ORLEANS — A consensus statement on managing diabetic ketoacidosis and hyperosmolar hyperglycemic state for adults with diabetes focuses on preventing recurrence and providing people with the tools to maintain glycemic control.

Men with low testosterone concentrations had a higher risk for all-cause mortality, and those with very low testosterone also had an increased risk for CVD mortality, a study in Annals of Internal Medicine showed.

Women with obesity who undergo bariatric surgery and have higher levels of insulin have a lower risk for breast cancer than women who do not undergo surgery, according to findings published in JAMA Surgery.

Women reporting irregular menstrual cycles with or without diagnosed polycystic ovary syndrome are more likely to have cardiometabolic conditions such as diabetes and hypertension, according to new data from the Apple Women’s Health Study.